ART-Plan+ (v3.1.0)
510(k) K253091
ART-Plan+ (v3.1.0) is a medical device (FDA Class II; FDA product code MUJ, System, Planning, Radiation Therapy Treatment) made by Therapanacea Sas, cleared under FDA 510(k) K253091 on 23 Dec 2025, active as of 22 Oct 2026.
Active
510(k)
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK253091 | Date23 Dec 2025 | StatusActive |
Official records
- FDA 510(k) database K253091
From the FDA record
- Received by the FDA
- 23 Sep 2025
- FDA decision
- 23 Dec 2025 (Substantially Equivalent)
- FDA review time
- 91 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- MUJ
- Device class
- Class II
- Regulation
- 21 CFR Part 892.5050
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Similar devices
Other devices filed under FDA product code MUJ (System, Planning, Radiation Therapy Treatment).
- RayStation 12A by RaySearch Laboratories AB (PUBL)
- FOCUS by Computerized Medical Systems, Inc.
- RT ELEMENTS, DOSE REVIEW, BRAIN METASTASES, ADAPTIVE HYBRID SURGERY ANALYSIS by Brainlab AG
- Monaco RTP System by ELEKTA SOLUTIONS AB
- XIO RTP SYSTEM by Computerized Medical Systems, Inc.
- .decimal Astroid Dosimetry App by .Decimal, LLC
- RADCALC SOFTWARE, VERSION 6.0 by LifeLine Software
- MODIFICATION TO ECLIPSE TREATMENT PLANNING SYSTEM by Varian Medical Systems, Inc.
- Eclipse Treatment Planning System (18.1) by Varian Medical Systems, Inc
- OTP 1.2 by Nucletron Corp.